Nitric oxide (NO)-related pharmaceuticals: Contemporary approaches to therapeutic NO modulation

被引:48
作者
Janero, DR [1 ]
机构
[1] NitroMed Inc, Bedford, MA 01730 USA
关键词
free radical; nitric oxide; sexual dysfunction; restenosis; nonsteroidal anti-inflammatory drug; gastrointestinal toxicity; drug discovery and development; pharmaceuticals;
D O I
10.1016/S0891-5849(00)00247-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The biologically important gaseous radical, nitric oxide (NO), is a versatile chemical entity that enters into regulatory, protective, and adverse interactions with biomolecules and cells, in some cases through NO-derived nitrogen oxide species. Both excess tissue NO and its insufficiency have been implicated in the genesis or evolution of several important disease states. The associated medical needs and commercial opportunities have fostered attempts to modulate tissue NO tone for symptomatic benefit or therapeutic gain. State-of-the-art strategies for NO modulation in contemporary drug discovery and development encompass sexual dysfunction, cardiovascular, and antiinflammatory indications. Increased understanding of NO's physiological chemistry and ways to target its pharmacology appear critical to the successful clinical exploitation of NO's diverse properties. Integration of research on both the basic science of NO's mechanistic biology and the applied science of drug discovery and development represents a millennium mandate to the pharmaceutical industry in the area of NO-related therapeutics. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:1495 / 1506
页数:12
相关论文
共 95 条
  • [11] Nitric oxide and its role in apoptosis
    Brüne, B
    von Knethen, A
    Sandau, KB
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 351 (03) : 261 - 272
  • [12] NITRIC-OXIDE - A PHYSIOLOGICAL MEDIATOR OF PENILE ERECTION
    BURNETT, AL
    LOWENSTEIN, CJ
    BREDT, DS
    CHANG, TSK
    SNYDER, SH
    [J]. SCIENCE, 1992, 257 (5068) : 401 - 403
  • [13] Buvat J, 1996, Int J Impot Res, V8, P41
  • [14] Cardillo C, 1998, Vasc Med, V3, P138, DOI 10.1177/1358836X9800300208
  • [15] Nitric oxide synthases:: targets for therapeutic strategies in neurological diseases
    Chabrier, PE
    Demerlé-Pallardy, C
    Auguet, M
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (8-9) : 1029 - 1035
  • [16] Nitric oxide and iron proteins
    Cooper, CE
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1999, 1411 (2-3): : 290 - 309
  • [17] De Tejada IS, 1999, J PHARMACOL EXP THER, V290, P121
  • [18] Guanylate cyclase and the .NO/cGMP signaling pathway
    Denninger, JW
    Marletta, MA
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1999, 1411 (2-3): : 334 - 350
  • [19] Gene therapy for restenosis - Are we ready?
    DeYoung, MB
    Dichek, DA
    [J]. CIRCULATION RESEARCH, 1998, 82 (03) : 306 - 313
  • [20] Basic science and pharmaceutical innovation
    Drews, J
    [J]. NATURE BIOTECHNOLOGY, 1999, 17 (05) : 406 - 406